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Background: Scabies, an infectious disease caused by Sarcoptes scabiei mites, is still one of the most common skin diseases 
found in developing countries, including Indonesia. The 5% permethrin cream for scabies treatment has been investigated as 
having 2–3 time to cure scabies. Tea Tree Oil (TTO) is one of the agents that has been proven to have acaricidal potential as 
an anti-inflammatory, antibacterial, and antipruritic agent. It has minimal side effects in topical use. Purpose: To evaluate the 
effectiveness of 5% TTO cream and 10% TTO cream in scabies treatment of pediatric patients. Methods: This was an 
experimental, analytical study with controlled clinical trial methods, and a double-blind, parallel design comparing 5% TTO 
cream (treatment 1), 10% TTO cream (treatment 2), with 5% permethrin cream (control) to children with scabies. Result: The 
5% TTO cream gave a cure rate of 61.5% and was significantly different from the 5% permethrin cream groups with a p-value 
= 0.044 in the first week of the study. The 5% permethrin cream gave a cure rate of 15.4%, and the cure rate of 10% TTO 
cream was 53.8% in the first week of the study. Conclusion: There was a significant difference between the 5% TTO cream 
and 5% permethrin cream in the first week of the study. The highest and fastest cure rates were found in the 5% TTO cream 
treatment group. 
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INTRODUCTION 
Scabies, an infectious disease caused by 
Sarcoptes scabiei mite, is still one of the most common 
skin diseases found in developing countries, including 
Indonesia. Every year, there are approximately 300 
million cases of scabies in worldwide.1 Symptoms of 
this disease are severe itching, especially at night with 
clinical manifestations of papules and pustules 
accompanied by tunnel-shaped lesions where S. scabiei 
is lodged in the epidermis. Scabies also causes 
complications such as rheumatic fever, nephritis, and 
sepsis, which are caused by secondary infection by 
Group A Streptococcus sp. or Staphylococcus aureus.2 
Scabies is generally occurred in low economic areas, 
areas with limited resource, and areas where people 
have to live in close proximity such as prisons, nursing 
homes, and dormitories. In addition, low socio-
economic conditions, lack of hygiene, crowded 
neighborhoods, lack of nutrition, and sexual behavior 
are risk factors for the spread of scabies.3 
Although scabies is a highly prevalent disease and 
potentially cause life-threatening complications, there 
has been not enough attention that is still considered a 
neglected disease. Treatment for scabies has now been 
investigated to have alarming local and systemic side 
effects, and its safety has not yet known in elderly 
patients, patients with impaired liver function, in 
patients younger than five years old, and in pregnant 
women. Several studies conducted in Australia found 
that the survival time of S. scabiei after exposure to 
acaricide drugs has increased to 2 to 3 times compared 
to 10 years ago.1 
The diagnosis of scabies is made through clinical 
manifestations and microscopic examination. 
Identifying lesions can be difficult because it often 
becomes unclear due to eczema or impetigo. A 
presumptive diagnosis can be made based on a history 
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have to live in close proximity such as prisons, nursing 
homes, and dormitories. In addition, low socio-
economic conditions, lack of hygiene, crowded 
neighborhoods, lack of nutrition, and sexual behavior 
are risk factors for the spread of scabies.3 
Although scabies is a highly prevalent disease and 
potentially cause life-threatening complications, there 
has been not enough attention that is still considered a 
neglected disease. Treatment for scabies has now been 
investigated to have alarming local and systemic side 
effects, and its safety has not yet known in elderly 
patients, patients with impaired liver function, in 
patients younger than five years old, and in pregnant 
women. Several studies conducted in Australia found 
that the survival time of S. scabiei after exposure to 
acaricide drugs has increased to 2 to 3 times compared 
to 10 years ago.1 
The diagnosis of scabies is made through clinical 
manifestations and microscopic examination. 
Identifying lesions can be difficult because it often 
becomes unclear due to eczema or impetigo. A 
presumptive diagnosis can be made based on a history 
of typical pruritus, pruritus that gets worse at night, 
distribution of the lesion, and a history of contact with 
other scabies patients. Definitive diagnosis is through 
microscopic findings of scabies mites, eggs, pieces of 
eggshell, or fecal matter (scybala) taken from a skin 
scraping from papules or under the nails. On 
dermoscopy, S. scabiei looks like a dark triangular 
shape resembling the letter "V". In the absence of mites 
found or negative dermoscopic examination, the 
diagnosis is based on clinical findings and 
epidemiology.4,5 
Tea Tree Oil (TTO) is a derivate of essential oil 
attained from the distillation of leaves and terminal 
branches of the Melaleuca alternifolia plant. TTO is a 
colorless or pale yellowish liquid, clear, and has a scent 
of terpenes, conifer, and minty, camphoraceous. TTO 
is an agent that has been proven in vivo and in vitro to 
have an acaricidal potential. TTO has three main 
components, namely terpinene-4-ol, γ-terpinene, and 
α-terpinene, which has anti-inflammatory, 
antibacterial, and antipruritic properties, with very 
minimal side effects in topical use. Topical TTO 
preparations will have several advantages as scabies 
therapy, which are more economical, easy to use, and 
can be implemented in various communities as a 
traditional medicine.1  
TTO has a promising acaricidal effect against 
scabies mites in vitro. It has been used successfully as 
a topical adjuvant treatment in the treatment of crusted 
scabies, including cases that do not respond to standard 
therapy. The combined effects of acaricidal, 
antibacterial, antipruritic, anti-inflammatory, and 
wound healing effects on TTO can potentially reduce 
scabies infection due to bacterial complications.1,6 TTO 
has been used as a remedy for several diseases such as 
acne, eczema, skin infections such as herpes simplex 
and warts, wounds, burns, insect bites, dandruff, and 
nail mycosis.6 TTO as essential oil is also used as 
therapy for dermatosis, respiratory infection, oral and 
vaginal, and antiseptic and disinfectant.6  
Terpinen-4-ol, at 0.125% concentration, can 
inhibit the production of several inflammatory 
mediators, such as tumor necrosis factor α, interleukin-
1β, and prostaglandin E2, equivalent to the production 
of superoxide, thereby reducing the inflammatory 
response. TTO has been shown to reduce the 
inflammatory response to the skin, including responses 
to insect bites, bee stings, hives/itches, and metal-
induced hypersensitivity. This is due to the ability of 
TTO to modulate vasodilation and plasma 
extravasation related to inflammation caused by 
histamine.1,8 
Various compounds in TTO have different use 
profiles. For example, terpinen-4-ol, a major 
component of TTO, exhibits strong anti-inflammatory, 
antimicrobial and anti-tumor properties9, while 1.8-
cineole is an unwanted allergen in TTO products. The 
anti-inflammatory activity of TTO is mediated by the 
reduction of TNF α, IL-1, IL-8, prostaglandin E, and 
superoxide monocytes. Topical TTO can regulate 
wheal and flare by reducing histamine-induced edema. 
TTO is an excellent alternative antioxidant. Its 
antioxidant activity reflects the properties of α-
terpinene, α-terpinolene, and γ-terpinene.8 
There are no studies that examine the 
effectiveness of acaricide drugs. Permethrin 5% works 
by blocking sodium channels in parasitic organs that 
can cause paralysis and arthropod death. The 
mechanism of the 5% TTO as an acaricide drug is 
thought to be the same as that of other acaricide drugs, 
blocking the sodium channel causing paralysis of the 
arthropods.10 TTO is believed to block the parasitic 
motility which causes elimination of the parasite from 
the host. One example of an anti-parasitic drug, 
Levamisole, works as an agonist on the nicotinic 
acetylcholine receptor in the parasitic neuromuscular 
junction, causing neuromuscular depolarization and 
spastic paralysis of the parasite.8 
The topical application of TTO has a low 
incidence of side effects. The most frequent side effects 
are irritant and allergic reactions to the oil. Irritant 
reactions can be significantly avoided through a lower 
concentration. Although the threshold limits for irritant 
reactions have not been described, TTO with 




This study was an experimental, analytical study 
using controlled clinical trial methods, random pair 
selection, and a double-blind, parallel design 
comparing 5% TTO cream (treatment 1), 10% TTO 
cream (treatment 2) with 5% permethrin cream 
(control) on child scabies. 
The inclusion criterion was scabies patients aged 
5 to 16 years old who were willing to participate in the 
study by signing informed consent. The diagnostic 
criteria for scabies are the presence of a burrow in the 
form of linear or winding and/or a typical scabies 
lesion, i.e., the discovery of papules or pustules in the 
area of scabies predilection, a complaint of itching, 
especially at night, and similar complaints in the family 
or close people were present, and/or the presence of 
triangular structure in the form of the letter 'V' in a 
dermoscopic examination, and/or one of the following 
is obtained from light microscopy: eggs, larvae, lice, or 
fleas. The exclusion criteria were patients with a 
secondary infection, patients with severe systemic 
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abnormalities, patients with immunosuppression, and 
Norwegian/crusted scabies.  
The sampling technique was consecutive, 
selecting participants who pass the inclusion and 
exclusion criteria at the Nurul Cholil Islamic Boarding 
School in Bangkalan.  A total of 39 samples were then 
divided into three groups, and each group consisted of 
13 people. The allocation of samples to the treatment 
and control group was done randomly.  
The procedure and objective of the study were 
conveyed to the eligible samples and their guardians, 
and if they are willing to participate in the research, 
informed consent will be signed by the representative 
of the Nurul Cholil boarding school, Bangkalan. 
Subjects were interviewed, then underwent physical 
examinations to measure weight and height, inspect 
and palpate the location of the complaint, conduct a 
dermoscopy examination, and dermal lesion scrapings. 
The subjects were then prescribed with cream for night 
use after they shower. The subjects applied the cream 
all over their bodies, including the crease areas and 
areas without complaints, as instructed. The cream was 
left for 8 hours and rinsed in the following day. The 
cream can be reapplied once a week if there is positive 
sign of scabies, established by a doctor’s physical 
examination.  
In the following week, the first week, the first 
evaluation included physical examination, dermoscopy 
examination, and scrapping examination. If all 
examinations showed negative results, the subject 
would be declared cured. If one of the examinations 
showed a positive result, the subject would be 
prescribed with the cream for the second time (the first 
repetition). The second evaluation was carried out in 
the following week, the second week, using the same 
method and criteria. Should the tests showed at least 
one positive result, the subject would receive the 
treatment for the third time (the second repetition) and 
re-evaluate the following week, which was the last 
evaluation. If one of the test results showed positive, 
then the research subject would be declared not cured. 
 
RESULTS 
This research is a clinical trial conducted in 
August to October 2019 aimed to compare the 5% TTO 
cream and 10% TTO cream to 5% permethrin cream, 
which has been used as standard therapy in treating 
scabies in this research. Subjects who participated in 
this study were patients who had positive results on 
physical examination and positive results on either 
scrapping or dermoscopic examinations for scabies 
infection. Two positive results from the three 
examinations aim to increase the diagnostic value of 
scabies in this study. Thirty-nine subjects participated 
in this study, and they were divided into 3 treatment 
groups, consisting of 13 participants each group. Each 
group received 5% permethrin cream, 5% TTO cream, 
10% TTO cream, respectively. This was a double-blind 
study in which the creams had identical packaging and 
numbered accordingly. Therefore, only the researcher 
knew which cream was which. 
Table 1 shows that most research subjects were 
males, amounting to 82.1%. The Pearson Chi-Square 
test shows a value of p = 0.498, which means that the 
data distribution of sex in the three study groups was 
not different. The high prevalence of scabies in male 
children was possible because of the sex ratio. There 
were 2,000 males and 1,200 females in Nurul Cholil 
Islamic boarding school. Also, males’ poorer self-
hygiene and care may contribute to the disease. 
Females tend to be more attentive to complaints and are 
responsive to seek treatment compared to males. Poor 
self-hygiene behaviors include sharing towels, sharing 
bed which facilitates skin-to-skin contact with scabies 
sufferers, and not immediately wash clothes after use.13 
The age range of the subjects was 10–16 years 
old. A retrospective study conducted by Paramita in 
2015 on scabies in the Dermatology and Venerology 
Outpatient Clinic of Dr. Soetomo General Academic 
Hospital, Surabaya states that the highest prevalence 
(63.8% of 282 patients) of scabies was observed in 4–
14 years age group.14 Kruskal Wallis p score was 0.257, 
which means that no difference in terms of age range 
between the study groups. This was because the 
majority of research subjects were in the same age 
group (early teens), where someone has begun to 
understand pay attention to their health. Early 
adolescence is a turning point age where someone 
interacts more with other people. Scabies that infects 
skin between fingers and toes and are visible. This can 
cause embarrassment and inferiority. As many as 80% 
of scabies patients claim that this disease affects their 
quality of life, including sleep disorders, community 
stigma, and causes shame.15,16 
Table 2 shows the comparison of cure rates 
between 5% permethrin cream and 5% TTO cream. 
The cure rate of 5% permethrin cream was 15.4%, and 
the cure rate of 5% TTO cream was 61.5%. The 
statistical analysis using the Pearson Chi-square test 
showed a p-value of 0.044. It means that there were 
significant differences between the two groups.  
The statistical analysis of the 5% Permethrin 
cream and 10% TTO cream resulted in a p-value of 
0.097. It means that there was no significant difference 
between the two groups. The 5% permethrin cream had 
a cure rate of 15.4%, and the 10% TTO cream had a 
53.8% cure rate. A similar result was obtained from a 
comparison between 5% TTO cream and 10% TTO 
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Table 2 shows the comparison of cure rates 
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Table 1. Characteristics of the research subjects 
Variable 








   Male 













   10  
   11  
   12  
   13  
   14  
   15  





























(BMI, kg/m2)  
 Underweight 
 (BMI <18.5) 
 Normal 
 (BMI 18.5–22.9) 
 Overweight 
 (BMI 23–29.9) 































BMI=  Body Mass Index; TTO= Tea Tree Oil 
 
Table 2. Treatment outcomes of 5% permethrin cream and 5% Tea Tree Oil cream 
 Week 1 Week 2 Week 3 
Permethrin 5% (n=13) (n=11) (n=8) 
Cured 2 (15.4%) 3 (27.3%) 3 (37.5%) 
Not Cured 11 (84.6%) 8 (72.7%) 5 (62.5%) 
TTO 5% (n=13) (n=5) (n=2) 
Cured 8 (61.5%) 3 (60%) 0 (0%) 
Not cured 5 (38.5%) 2 (40%) 2 (100%) 
p value (Chi Square) 0.044   
TTO = Tea Tree Oil 
 
Table 3. Treatment outcomes of 5% permethrin cream and 10% Tea Tree Oil cream 
 Week 1 Week 2 Week 3 
Permethrin 5% (n=13) (n=11) (n=8) 
Cured 2 (15.4%) 3 (27.3%) 3 (37.5%) 
Not cured 11 (84.6%) 8 (72.7%) 5 (62.5%) 
TTO 10% (n=13) (n=6) (n=5) 
Cured 7 (53.8%) 1 (16.7%) 0 (0%) 
Not cured 6 (46.2%) 5 (83.3%) 5 (100%) 
p value (Chi Square) 0.097   
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Table 4. Treatment outcomes of 5% Tea Tree Oil cream and 10% Tea Tree Oil cream 
 Week 1 Week 2 Week 3 
TTO 5% cream (n=13) (n=5) (n=2) 
Cured 8 (61.5%) 3 (60%) 0 (0%) 
Not cured 5 (38.5%) 2 (40%) 2(100%) 
TTO 10% (n=13) (n=6) (n=5) 
Cured  7 (53.8%) 1 (16.7%) 0 (0%) 
Not cured 6 (46.2%) 5 (83.3%) 5(100%) 
p value (Chi Square) 1.000   
TTO= Tea Tree Oil 
 








Permethrin 5% 2 (5.1%) 3 (13.6%) 3 (20%) 
TTO 5% 8 (20.5%) 3 (13.6%) 0 (0%) 
TTO 10% 7 (17.9%) 1 (4.5%) 0 (0%) 
Total 17(43.5%) 7 (31.8%) 3 (20%) 
TTO = Tea Tree Oil 
 
Table 5 shows that the highest and fastest cure 
rates were found in the 5% TTO cream, a treatment 
group. In the first week of treatment, the 5% TTO 
group had the highest cure rate compared to the other 
two groups, which was 20.5% with a p-value of 0.044, 
indicating no significant difference between the 5% 
TTO cream group and the 5% permethrin cream. This 
was possibly because of Terpinen-4-ol found in TTO, 
which works by inhibiting the production of 
inflammatory mediators and paralyzing arthropods by 
blocking the sodium channel and the nicotinic 
acetylcholine receptor agonist in the neuromuscular 
junction of S. scabiei. Permethrin 5% only paralyzes S. 
scabiei; therefore, it makes sense that TTO can cure 
scabies more quickly. The use of 5% permethrin cream 
in treating scabies also gives excellent and satisfying 
results. The 5% permethrin cream is the most widely 
used first-line topical drug for scabies treatment, and 
some countries use it as the gold standard of therapy. 
Research conducted by Goldust found that treatment 
using 5% permethrin achieved a cure rate of 92.5% in 
the second week of treatment.10 
This study concluded that there were significant 
differences between 5% TTO cream and 5% 
permethrin cream in scabies treatment in the first week. 
Environment is one of the factors that could not be 
controlled in this study. Dense populations and close 
interactions can cause reinfection and hinder the 
healing process. Environmental control, such as 
personal hygiene and comprehensive management, can 
increase the successful rate of therapy. 
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Table 4. Treatment outcomes of 5% Tea Tree Oil cream and 10% Tea Tree Oil cream 
 Week 1 Week 2 Week 3 
TTO 5% cream (n=13) (n=5) (n=2) 
Cured 8 (61.5%) 3 (60%) 0 (0%) 
Not cured 5 (38.5%) 2 (40%) 2(100%) 
TTO 10% (n=13) (n=6) (n=5) 
Cured  7 (53.8%) 1 (16.7%) 0 (0%) 
Not cured 6 (46.2%) 5 (83.3%) 5(100%) 
p value (Chi Square) 1.000   
TTO= Tea Tree Oil 
 








Permethrin 5% 2 (5.1%) 3 (13.6%) 3 (20%) 
TTO 5% 8 (20.5%) 3 (13.6%) 0 (0%) 
TTO 10% 7 (17.9%) 1 (4.5%) 0 (0%) 
Total 17(43.5%) 7 (31.8%) 3 (20%) 
TTO = Tea Tree Oil 
 
Table 5 shows that the highest and fastest cure 
rates were found in the 5% TTO cream, a treatment 
group. In the first week of treatment, the 5% TTO 
group had the highest cure rate compared to the other 
two groups, which was 20.5% with a p-value of 0.044, 
indicating no significant difference between the 5% 
TTO cream group and the 5% permethrin cream. This 
was possibly because of Terpinen-4-ol found in TTO, 
which works by inhibiting the production of 
inflammatory mediators and paralyzing arthropods by 
blocking the sodium channel and the nicotinic 
acetylcholine receptor agonist in the neuromuscular 
junction of S. scabiei. Permethrin 5% only paralyzes S. 
scabiei; therefore, it makes sense that TTO can cure 
scabies more quickly. The use of 5% permethrin cream 
in treating scabies also gives excellent and satisfying 
results. The 5% permethrin cream is the most widely 
used first-line topical drug for scabies treatment, and 
some countries use it as the gold standard of therapy. 
Research conducted by Goldust found that treatment 
using 5% permethrin achieved a cure rate of 92.5% in 
the second week of treatment.10 
This study concluded that there were significant 
differences between 5% TTO cream and 5% 
permethrin cream in scabies treatment in the first week. 
Environment is one of the factors that could not be 
controlled in this study. Dense populations and close 
interactions can cause reinfection and hinder the 
healing process. Environmental control, such as 
personal hygiene and comprehensive management, can 
increase the successful rate of therapy. 
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